FDA to weigh easing limits on peptides promoted by RFK Jr. NBC 6 South Florida Early evidence suggests BPC 157 repairs tissue rather than just dulling symptoms. To read more, tap the link in bio. The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157 for athletes and injury treatment: Science, safety, and legal concerns FDA to Convene Expert Panel on Expanding Access to Peptides Amid Safety, Regulatory Debate AJMC